Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
90.50
+5.73 (6.77%)
At close: Sep 26, 2025, 4:00 PM EDT
90.50
0.00 (0.01%)
After-hours: Sep 26, 2025, 7:32 PM EDT

Cidara Therapeutics Statistics

Total Valuation

CDTX has a market cap or net worth of $2.29 billion. The enterprise value is $1.79 billion.

Market Cap2.29B
Enterprise Value 1.79B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

CDTX has 25.36 million shares outstanding. The number of shares has increased by 153.66% in one year.

Current Share Class 25.36M
Shares Outstanding 25.36M
Shares Change (YoY) +153.66%
Shares Change (QoQ) +9.66%
Owned by Insiders (%) 0.51%
Owned by Institutions (%) 75.23%
Float 18.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.20
P/TBV Ratio 4.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 16.45, with a Debt / Equity ratio of 0.00.

Current Ratio 16.45
Quick Ratio 15.86
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -37.05% and return on invested capital (ROIC) is -26.16%.

Return on Equity (ROE) -37.05%
Return on Assets (ROA) -23.61%
Return on Invested Capital (ROIC) -26.16%
Return on Capital Employed (ROCE) -26.63%
Revenue Per Employee n/a
Profits Per Employee -$3.09M
Employee Count38
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +736.37% in the last 52 weeks. The beta is 1.29, so CDTX's price volatility has been higher than the market average.

Beta (5Y) 1.29
52-Week Price Change +736.37%
50-Day Moving Average 65.62
200-Day Moving Average 35.42
Relative Strength Index (RSI) 74.38
Average Volume (20 Days) 916,699

Short Selling Information

The latest short interest is 2.19 million, so 8.65% of the outstanding shares have been sold short.

Short Interest 2.19M
Short Previous Month 2.15M
Short % of Shares Out 8.65%
Short % of Float 11.68%
Short Ratio (days to cover) 4.37

Income Statement

Revenue n/a
Gross Profit -108.72M
Operating Income -133.67M
Pretax Income -117.10M
Net Income -117.49M
EBITDA -133.53M
EBIT -133.67M
Earnings Per Share (EPS) -$10.21
Full Income Statement

Balance Sheet

The company has $510.58 million in cash and $2.33 million in debt, giving a net cash position of $508.24 million or $20.04 per share.

Cash & Cash Equivalents 510.58M
Total Debt 2.33M
Net Cash 508.24M
Net Cash Per Share $20.04
Equity (Book Value) 501.17M
Book Value Per Share 21.57
Working Capital 499.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$129.02 million and capital expenditures -$106,000, giving a free cash flow of -$129.13 million.

Operating Cash Flow -129.02M
Capital Expenditures -106,000
Free Cash Flow -129.13M
FCF Per Share -$5.09
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CDTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -153.66%
Shareholder Yield -153.66%
Earnings Yield -5.12%
FCF Yield -5.63%

Analyst Forecast

The average price target for CDTX is $80.90, which is -10.60% lower than the current price. The consensus rating is "Strong Buy".

Price Target $80.90
Price Target Difference -10.60%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (5Y) 174.56%
EPS Growth Forecast (5Y) -33.85%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on April 24, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date Apr 24, 2024
Split Type Reverse
Split Ratio 1:20

Scores

CDTX has an Altman Z-Score of 2.13 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.13
Piotroski F-Score 1